PFE, Pfizer update

Again the then, Dec. 2010, and now charts;

pfe dec 2010pfe sept 2012

There are various blogs in between advising exiting the position and, in contradiction to that, waiting for targets at $24 and $28 (all are in the archives). You are up about 40% if you held on to this stock from Dec. 10 onwards. Now that things are a little clearer we would prefer the A-B-C count as opposed to the 1-2-3-4-5 possibility. The two legs are roughly equal in size if not in an absolute sense than proportionately and both the RSI and MACD have been turning down for some time.  The same holds for BAX, Baxter.